Physician profile
Ramesh Daggubati
NPI 1083600522
$53,522.59
in general payments reported to CMS, 2019-2025
26 companies · $26K in 2025
The $26K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,745 · 2020: $1,282 · 2021: $3,258 · 2022: $2,699 · 2023: $4,116 · 2024: $9,476 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $14K · Food and Beverage: $8,677 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,525.00 |
| Travel and Lodging | $14,336.00 |
| Food and Beverage | $8,676.68 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $27,662.61 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Angiodynamics, INC. | $5,356.58 | 2019-2025 | Alphavac, Angiovac, Auryon Laser System 100-120 Vac |
| W. L. Gore & Associates, INC. | $4,682.97 | 2019-2022 | |
| Boston Scientific Corporation | $4,233.09 | 2019-2025 | Watchman Access System, Avvigo Guidance System, Watchman Flx |
| Edwards Lifesciences Corporation | $4,182.47 | 2021-2025 | Evoque, Pascal, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $3,836.39 | 2019-2025 | Amplatzer Talisman, Amplatzer Amulet, Navitor |
| Medtronic Vascular, INC. | $1,066.34 | 2019-2020 | |
| Abiomed | $649.42 | 2019-2024 | Impella |
| Philips North America LLC | $325.57 | 2019-2025 | Azurion 7 B20, Coronary Other |
| Cardiovascular Systems INC. | $274.91 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $194.04 | 2019 | |
| Celonova Biosciences, INC. | $167.99 | 2019 | |
| Stryker Corporation | $156.66 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $136.57 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $78.55 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $70.99 | 2024 | Remede System |
| Siemens Medical Solutions USA, INC. | $65.44 | 2021-2022 | |
| Vital Connect, INC | $58.39 | 2023 | Vitalpatch Rtm |
| Irhythm Technologies, INC. | $56.11 | 2021 | |
| Biotronik INC. | $54.50 | 2021 | |
| Endotronix, INC. | $52.16 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Impulse Dynamics (USA) INC. | $50.13 | 2023 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.19 | 2019 | |
| Lantheus Medical Imaging, INC. | $36.56 | 2023 | Definity |
| Biosense Webster, INC. | $22.52 | 2022 | |
| Amgen INC. | $14.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramesh Daggubati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.